Web Results

Zanamivir

en.wikipedia.org/wiki/Zanamivir

Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses.

Relenza (Zanamivir) Drug Information: Description, User Reviews ...

www.rxlist.com/relenza-drug.htm

Learn about the prescription medication Relenza (Zanamivir), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.

Zanamivir Oral Inhalation: MedlinePlus Drug Information

www.nlm.nih.gov/medlineplus/druginfo/meds/a699021.html

Jul 1, 2010 ... Zanamivir is used in adults and children at least 7 years of age to treat some types of influenza ('flu') in people who have had symptoms of the ...

Zanamivir: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/zanamivir.html

Easy to read patient leaflet for zanamivir. Includes indications, proper use, special instructions, precautions, and possible side effects.

CDC Considerations Related to Investigational Use of Intravenous ...

www.cdc.gov/flu/professionals/antivirals/intravenous-antivirals.htm

Feb 22, 2016 ... This page provides guidance specific to the use of investigational use of intravenous zanamivir, but not for the use of FDA-approved ...

Influenza Textbook | Zanamivir - Influenza Report

www.influenzareport.com/ir/drugs/zanami.htm

Zanamivir is an orally inhaled powder currently approved in 19 countries for the treatment of, and in two for the prophylaxis of influenza A and B. Zanamivir is a ...

Relenza [zanamivir for inhalation] - GSK Source

www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Relenza/pdf/RELENZA-PI-PIL-COMBINED.PDF

RELENZA (zanamivir) Inhalation Powder, for oral inhalation. Initial U.S. Approval: .... (zanamivir) Inhalation Powder is indicated for treatment of uncomplicated.

Relenza (zanamivir) - NetDoctor

www.netdoctor.co.uk/medicines/infections/a7864/relenza-zanamivir/

Dec 17, 2013 ... Relenza inhalation powder contains the active ingredient zanamivir, which is a type of medicine called a neuraminidase inhibitor. It is used to ...

Relenza (zanamivir) dosing, indications, interactions, adverse ...

reference.medscape.com/drug/relenza-zanamivir-342636

Medscape - Indication-specific dosing for Relenza (zanamivir), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...

(zanamivir) Information - U.S. Food and Drug Administration

www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm183783.htm

Dec 16, 2015 ... Relenza (zanamivir) is approved for treatment of acute uncomplicated illness due to influenza A and B in patients 7 years of age and older.

Answer
Zanamivir Highlights
ZANAMIVIR (za NA mi veer) is an antiviral medicine. It is used to prevent and treat flu infections caused by influenza A or B virus. It will not work for colds, other types of flu, or other viral infections. More »
Source: healthline.com
More Info

zanamivir, Relenza: Drug Facts, Side Effects and Dosage

www.medicinenet.com

Jan 6, 2015 ... Learn about zanamivir (Relenza) a drug prescribed for the treatment of flu viruses A and B (including H1N1 or swine flu). Side effects, drug ...

DrugBank: Zanamivir

www.drugbank.ca

Name, Zanamivir. Accession Number, DB00558 (APRD00378). Type, Small Molecule. Groups, Approved, Investigational. Description. A guanido-neuraminic  ...

Zanamivir medical facts from Drugs.com

www.drugs.com

Physician reviewed zanamivir patient information - includes zanamivir description, dosage and directions.